Escalating violence across the Middle East sent energy futures rallying Monday morning, as markets grappled with damaged infrastructure and the collapse of critical diplomatic talks. The unrest, fueled by persistent attacks on Red Sea shipping, pushed crude benchmarks and refined product prices to their highest levels in months.
Pinterest is deploying a unified artificial intelligence layer powered by Nvidia's Blackwell GPUs, shifting away from fragmented product development. By integrating visual embeddings with accelerated computing, the social platform aims to scale its image-and-language tools—ranging from safety moderation to advanced shopping assistants—without building custom infrastructure for every new feature.
Chewy shares climbed 5.1% to $21.49 Monday, a rare positive movement for a stock that has shed 35% of its value this year. The uptick follows the online retailer’s filing of a shelf registration statement, a procedural maneuver designed to grant the company rapid access to capital markets when conditions align.
As broader tech markets falter under fears that artificial intelligence development may soon face federal or industry-imposed constraints, cybersecurity firms are bucking the trend. Investors are pouring capital into security providers, betting that the escalating risks posed by autonomous, self-improving models will make these companies essential infrastructure for the digital future.
U.S. export inspections for soybeans and wheat saw a weekly uptick as of September 10, according to Department of Agriculture data. While soybean volumes climbed to 672,759 metric tons and wheat reached 456,720 tons, corn exports retreated, slipping to 1.53 million tons from the previous week's 1.67 million.
Investors reacted sharply to Corning’s announcement of a new equity program, sending the company’s share price down 12% to $145.69 on Monday morning. The materials science firm revealed late Friday that it intends to raise as much as $2 billion by selling common stock through an at-the-market distribution agreement.
Thirty-year U.K. government bond yields climbed to their highest level since 1998 on Monday, fueled by a sharp spike in oil prices and growing investor anxiety over the upcoming national budget. The bond market selloff reflects deep-seated concerns that persistent inflation will force prolonged interest rate hikes.
Investors pushed Tyra Biosciences shares up 11% to $24.44 in morning trade after the biotechnology firm priced a massive $400 million public offering. The company successfully moved 9.08 million shares at $22.03 each, alongside pre-funded warrants, marking a significant capital injection for its clinical pipeline.
Roof leaks, makeshift umbrellas, and malfunctioning dryers defined the production environment at Abbott Laboratories facilities for years. The healthcare giant agreed to pay $385 million to resolve government allegations that it knowingly sold infant formula produced under conditions that failed to meet basic safety and regulatory standards.
The Federal Reserve’s upcoming interest-rate decision stands as the primary macro catalyst for agricultural commodities this week, with analysts warning that a rate hike could exert downward pressure on prices. Beyond monetary policy, shifting weather patterns and geopolitical tensions remain central to market volatility across grains and soft commodities.
A sudden power failure forced the 275,000 barrel-per-day ExxonMobil refinery in Channahon, Illinois, into a complete shutdown on Sunday afternoon. The facility, a major regional processing hub, lost electricity at approximately 3:30 p.m., triggering an immediate emergency response to secure the complex and manage the impact of the outage.
Amazon, Netflix and Google’s YouTube have launched the Streaming Access and Choice Alliance, a new coalition aimed at influencing federal policy regarding digital content. Led by the advocacy group TechNet, the alliance intends to push for regulatory frameworks that prioritize viewer flexibility and continued innovation in the streaming sector.
Bally’s shares climbed 9% to $10 on Monday, signaling a rare moment of investor optimism after the company secured $560 million in financing commitments. The capital is earmarked for its ambitious $4 billion Bronx resort project, an aggressive expansion plan that has faced significant scrutiny throughout a volatile fiscal year.
A 6% surge in midday trading signaled investor optimism as AeroVironment’s recently acquired BlueHalo unit secured a $99.8 million contract from the U.S. Air Force. The deal marks a significant milestone for the defense firm, which has faced a difficult year with shares sliding 36% since January.
Fomento Económico Mexicano shares climbed 3.1% to $120.62 in Monday afternoon trading after the retail and beverage giant launched an accelerated share repurchase agreement. This move to buy back $280 million in American depositary shares marks a significant milestone for the firm, which has seen its stock gain 19% this year.
BioNTech’s American depositary receipts climbed 3.7% to $110.34 Monday after the company announced its experimental lung cancer treatment, gotistobart, nearly doubled median survival rates in a Phase 3 trial, outperforming standard chemotherapy in patients who had exhausted previous treatment options.
PBF Energy shares tumbled 7% to $72.73 on Monday following the company’s announcement of a $500 million exchangeable notes offering due 2032. Despite the sharp intraday decline, the petroleum refiner’s stock valuation has nearly tripled over the course of this year, reflecting a broader period of significant growth.
Federal energy officials have mandated that TransAlta keep its Centralia Generating Station operational for an additional 90 days, citing an urgent need to maintain grid reliability. This latest directive forces the facility to remain available through December 12, further delaying the long-planned decommissioning of the state's final coal-fired unit.
The neon-lit streets of Las Vegas now serve as the latest testing ground for Alphabet’s autonomous fleet. Waymo confirmed on Monday that it has officially opened its driverless ride-hailing operations to the general public, marking a significant expansion of the company’s reach across the Nevada desert.
Investors pushed Stewards shares down 9% to $2.69 on Monday as the financial platform disclosed fresh details regarding its proposed acquisition of two South Florida multifamily properties. Trading volume surged to 966,000 shares, more than double the company's 65-day average, reflecting heightened market sensitivity to the expansion strategy.
The 10-year U.S. Treasury yield retreated Monday after breaching the 5% threshold for the first time since October 2023, tracking a volatile session in energy markets. Simultaneously, German Bund yields climbed to a 15-year peak of 3.538%, reflecting mounting investor anxiety over the persistence of global inflationary pressures.
Amazon has tapped international capital markets, finalizing the sale of 4.25 billion British pounds in notes. This multi-billion dollar injection, valued at approximately $5.74 billion, underscores the e-commerce giant's strategy to bolster its liquidity through long-term debt instruments maturing between 2029 and 2045.
A veteran of the gaming and private equity sectors, Adam Chibib is set to take the helm as chief financial officer at IGT. His appointment, effective November 1, marks a pivotal shift for the organization as it navigates the post-merger integration of its gaming, digital, and financial technology operations.
With U.S. oil futures climbing past $100 per barrel and diesel prices exceeding $6 a gallon, markets are bracing for a sharp contraction in consumption. The latest price spike follows targeted assaults on Saudi Arabia’s East-West pipeline, effectively choking off a vital bypass route for Persian Gulf crude exports.
Shares of Veea surged 41% in after-hours trading following the announcement of a proposed merger with NovaGen Group. The deal aims to fuse cyber infrastructure with clinical cellular science, creating a new entity called NovaGen Health Networks intended to reshape patient-controlled data and regenerative therapy pathways.
A convergence of cooling enthusiasm for artificial intelligence and a relentless surge in energy prices sent U.S. stocks into a retreat. The market correction arrived as investors braced for an imminent Federal Reserve rate hike while processing a rare plea from industry titans to decelerate the pace of AI development.
A 50% reduction in pSMAD3 proteins among patients treated with AGMB-447 has cleared the path for Agomab Therapeutics to launch a Phase 2 trial. The Belgian biopharmaceutical firm confirmed its candidate successfully inhibited the TGF-beta/ALK5 pathway during early-stage testing for idiopathic pulmonary fibrosis.
The Food and Drug Administration has granted breakthrough therapy designation to Rasonque, a treatment developed by Revolution Medicines for metastatic pancreatic adenocarcinoma. This regulatory milestone aims to accelerate the development timeline for the drug, which is currently being tested in combination with gemcitabine and nab-paclitaxel for patients facing this aggressive cancer.
Veracyte has secured a deal worth up to $180 million to acquire Convergent Genomics, adding the UroAmp urinary tumor DNA platform to its cancer diagnostics lineup. The transaction includes an immediate $150 million cash payment, with the remaining $30 million contingent upon the achievement of specific clinical and commercial milestones.
Shares of Contineum Therapeutics slid 8.2% in after-hours trading Monday, dropping to $13.59, as investors reacted to news that the company's Phase 2 trial for a depression treatment failed to hit its primary efficacy goal. The clinical disappointment casts a shadow over the firm’s pipeline development.
